# Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients

> **NIH NIH R43** · ALTALITY, INC. · 2022 · $255,996

## Abstract

PROJECT SUMMARY/ABSTRACT
Hispanic/Latino youth are at the highest risk for prescription opioid misuse for pain indications amongst all
minority populations in the United States. There are few legitimate clinical indications for prescribing opioids to
children and adolescents, as early opioid use is a known “gateway” to adulthood dependence and substance
abuse disorders. Cancer and major surgery are two critical medical conditions that when put together, cause
children and adolescents to experience significant pain from the time of diagnosis into adulthood as survivors
and put them at higher risk for persistent and chronic prescription opioid use and dependency. In perioperative
settings, clinical decisions on opioid prescribing are dependent on rapid, verbal communication of pain intensity
levels and adverse events between the clinical staff, the pediatric patient, and most often, family members in
the acute care setting. Spanish-speaking Hispanic/Latino patients and/or adult caregivers with limited English
proficiency are forced to rely on the availability of institutional translation services or the presence of bilingual
clinical staff, which may not be readily available or easy to use. These infrastructural barriers, exacerbated in
low or middle-income hospitals, put these patients at higher risk of inaccurate pain assessments, both under
and over-treatment of their pain, and exposure to inappropriate amounts of prescription opioids.
Our goal is to reduce inaccurate assessment and treatment of pain and opioid prescribing in Hispanic/Latino
children and adolescents with cancer undergoing major surgery with a rapid, dual English/Spanish-language,
age-appropriate, engaging mobile augmented reality (AR) tool that can help them and their families to
communicate information about their acute pain and pain-related adverse events in the immediate
postoperative inpatient setting. To achieve this goal, we have collaborated with bilingual native Spanish-
speaking pediatric anesthesiologists and pain specialists at the MD Anderson Cancer Center to develop the
app with content relevant and engaging to Hispanic and non-Hispanic pediatric populations and will
demonstrate the feasibility of implementing the app in the postoperative anesthesia care unit in a Phase I
clinical trial. To our knowledge, there are no studies to investigate mobile AR for enhancing pain management
focused on this population. As most children with cancer are expected to survive long-term, the benefits of
preventing inappropriate prescription opioid use in this high-risk pain population will last over the lifetime of a
child.

## Key facts

- **NIH application ID:** 10601606
- **Project number:** 1R43DA057744-01
- **Recipient organization:** ALTALITY, INC.
- **Principal Investigator:** Juan Pablo Cata
- **Activity code:** R43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $255,996
- **Award type:** 1
- **Project period:** 2022-09-30 → 2023-09-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10601606

## Citation

> US National Institutes of Health, RePORTER application 10601606, Feasibility of a dual English/Spanish mobile augmented reality pain assessment app to reduce postoperative prescription opioid use in Hispanic/Latino pediatric and adolescent cancer patients (1R43DA057744-01). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10601606. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*